YRGLM Inc.
YRGLM Inc. (3690.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for YRGLM Inc. (3690.T), featuring income statements, balance sheets, and cash flow data.
YRGLM Inc. (3690.T) Income Statement & Financial Overview
View the income breakdown for YRGLM Inc. 3690.T across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $1.21B | $1.17B | $906.41M | $878.00M |
| Cost of Revenue | $593.22M | $567.00M | $376.75M | $347.00M |
| Gross Profit | $621.36M | $600.00M | $529.66M | $531.00M |
| Gross Profit Ratio | $0.51 | $0.51 | $0.58 | $0.60 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $573.06M | $577.00M | $501.45M | $504.00M |
| Operating Expenses | $573.06M | $577.00M | $502.00M | $503.00M |
| Total Costs & Expenses | $1.17B | $1.14B | $878.20M | $850.00M |
| Interest Income | $0.00 | $2.58M | $0.00 | $1.00M |
| Interest Expense | $1.92M | $1.73M | $706000.00 | $0.00 |
| Depreciation & Amortization | $70.83M | $74.25M | $2.69M | $77.25M |
| EBITDA | $119.94M | $97.25M | $30.90M | $103.25M |
| EBITDA Ratio | $0.10 | $0.08 | $0.03 | $0.12 |
| Operating Income | $48.30M | $23.00M | $28.21M | $28.00M |
| Operating Income Ratio | $0.04 | $0.02 | $0.03 | $0.03 |
| Other Income/Expenses (Net) | -$1.11M | -$5.00M | -$550000.00 | $586000.00 |
| Income Before Tax | $47.19M | $18.00M | $27.66M | $28.00M |
| Income Before Tax Ratio | $0.04 | $0.02 | $0.03 | $0.03 |
| Income Tax Expense | $30.98M | $18.34M | $15.82M | $21.00M |
| Net Income | $22.77M | $4.00M | $9.62M | $7.00M |
| Net Income Ratio | $0.02 | $0.003 | $0.01 | $0.008 |
| EPS | $3.69 | $0.65 | $1.56 | $1.14 |
| Diluted EPS | $3.69 | $0.65 | $1.56 | $1.14 |
| Weighted Avg Shares Outstanding | $6.18M | $6.16M | $6.15M | $6.16M |
| Weighted Avg Shares Outstanding (Diluted) | $6.18M | $6.16M | $6.15M | $6.16M |
The company's financials show resilient growth, with revenue advancing from $878.00M in Q3 2024 to $1.21B in Q2 2025. Gross profit remained healthy with margins at 51% in Q2 2025 compared to 60% in Q3 2024. Operating income hit $48.30M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $119.94M. Net income rose to $22.77M, while earnings per share reached $3.69. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan